secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cadrenal Therapeutics, Inc. (CVKD)
CIK:        0001937993
Form:       8-K
Filed at:   2025-11-18T23:59:59+00:00
Accession:  0001213900-25-112123
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cadrenal Therapeutics files prospectus supplement for up to $3.4M ATM offering
------------------------------------------------------------------------------

- Filed prospectus supplement to sell up to $3,438,062 of common stock via ATM program with H.C. Wainwright.
- As of Nov 18, 2025, $9,386,964 of common stock already sold under the same ATM agreement dated March 11, 2024.
- Wainwright will receive 3.0% commission on gross sales; Company has no obligation to sell shares.
- Legal opinion from Blank Rome LLP attached as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937993/000121390025112123/0001213900-25-112123-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937993/000121390025112123/ea0266097-8k_cadrenal.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-112123

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer